1Bell AJ,Nicholls RJ,Forbes A,et al. Human lymphocyte stimula-tion with pouchitis flora is greater than with flora from a healthypouch but is suppressed by metronidazole [J].Gut, 2004, 53(12) : 1801-1805.
1Siddiqui A,Ancha H,Tedesco D,et al.Antioxidant therapy with N-acetylcysteine plus mesatamine accelerates mucosal healing in a rodent model of colitis.Dig Dis Sci,2006,51:698-705.
2Wallace JL,Keenan CM,Gale D,et al.Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis.Gastroenterology,1992,102:18-27.
3Morris GP,Beck PL,Herridge MS,et al.Hapten-induced model of chronic inflammation and ulceration in the rat colon.Gastroenterology,1989,96:795-803.
4Dotan I,Rachmilewitz D.Probiotics in inflammatory bowel disease:possible mechanisms of action.Curr Opin Gastroenterol,2005,21:426-430.
5Sarter RB.Mechanisms of disease:pathogenesis of Crohn's disease and ulcerative colitis.Nat Clin Pract Gastroenterol Hepatol,2006,3:390-407.
6Rembacken BJ,Shelling AM,Hawkey PM,et al.Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis:a randomized trial.Lancet,1999,354:635-639.
7Kruis W,Fric P,Pokrotnieks J,et al.Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.Gut,2004,53:1617-1623.
8Anand AC,Adya CM.Cytukines and inflammatory bowel disease.Trop Gastroenterol,1999,20:97-106.
9Rahimi R,Nikfar S,Abdollahi M.Meta-analysis technique confirms the effectiveness of anti-TNF-alpha in the management of active ulcerative colitis when administered in combination with corticosteroids.Med Sci Monit,2007,13:PI13-18.
10Dotan I,Rachmilewitz D.Probiotics in inflammatory bowel disease:possible mechanisms of action.Curr Opin Gastroenterol,2005.21:426-430.
